NCT00933569已完成3 期
Monocentric Study, Phase III, for Safety Dermatological Evaluation: Acceptability With Gynaecological Follow up Dermacyd Silver Floral (Lactic Acid).
适应症
干预措施
相关药物
试验速览
- 阶段
- 3 期
- 状态
- 已完成
- 发起方
- Sanofi
- 入组人数
- 31
- 试验地点
- 1
- 主要终点
- Evaluation of the absence of irritation and the good acceptability by using one specific scale which describes the intensity of the reaction.
研究概览
简要总结
Primary Objective:
To prove the safety of the gynaecological formulation in normal conditions of use.
研究设计
- 研究类型
- Interventional
- 分配方式
- Non Randomized
- 干预模型
- Single Group
- 主要目的
- Prevention
- 盲法
- None
入排标准
- 年龄范围
- 18 Years 至 65 Years（Adult, Older Adult）
- 性别
- Female
- 接受健康志愿者
- 是
入选标准
- 未提供
排除标准
- 未提供
研究组 & 干预措施
Dermacyd Silver Floral (Lactic Acid)
Experimental
Aplication of Dermacyd Silver Floral (Lactic Acid) during 21 consecutive days
干预措施: LACTIC ACID(ND) (Drug)
结局指标
主要结局
Evaluation of the absence of irritation and the good acceptability by using one specific scale which describes the intensity of the reaction.
时间窗: From the treatment start to the end of the study (treatment period 21 days)
次要结局
未报告次要终点
研究者
研究点 (1)
Loading locations...
相似试验
已完成
3 期
Dermacyd PH_DESILSTY_FL (Lactic Acid) - Acceptability - Stay on Floral.HygieneNCT00933699Sanofi32
已完成
3 期
Dermacyd PH_DESILSTY_FR (Lactic Acid) - Acceptability - Stay on FrutalHygieneNCT00932945Sanofi32
已完成
3 期
Dermacyd Silver Frutal (Lactic Acid) - Acceptability.HygieneNCT00933413Sanofi30
已完成
3 期
Safety Dermatological Evaluation: Acceptability With Gynecological Follow up - Dermacyd Tina Gel Sweet FlowerHygieneNCT00663273Sanofi30
已完成
3 期
Safety Dermatological Evaluation: Acceptability With Gynecological Follow up - Dermacyd BreezeHygieneNCT00664391Sanofi32